0000899243-17-029733.txt : 20171229
0000899243-17-029733.hdr.sgml : 20171229
20171229172637
ACCESSION NUMBER: 0000899243-17-029733
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171227
FILED AS OF DATE: 20171229
DATE AS OF CHANGE: 20171229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ADELMAN DANIEL C MD
CENTRAL INDEX KEY: 0001222037
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37519
FILM NUMBER: 171282748
MAIL ADDRESS:
STREET 1: 23 WOODLEAF AVENUE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94061
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc.
CENTRAL INDEX KEY: 0001631650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452748244
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
BUSINESS PHONE: (650) 614-5220
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
FORMER COMPANY:
FORMER CONFORMED NAME: Allergen Research Corp
DATE OF NAME CHANGE: 20150123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-27
0
0001631650
Aimmune Therapeutics, Inc.
AIMT
0001222037
ADELMAN DANIEL C MD
AIMMUNE THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 300
BRISBANE
CA
94005-1884
0
1
0
0
Chief Medical Officer
Common Stock, $0.0001 par value
2017-12-27
4
M
0
3283
11.45
A
3283
D
Common Stock, $0.0001 par value
2017-12-27
4
S
0
3283
40.00
D
0
D
Stock Option(right to buy)
11.45
2017-12-27
4
M
0
3283
0.00
D
2026-06-24
Common Stock
3283
226717
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on June 16, 2017 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date
/s/ Douglas T. Sheehy, as Attorney in Fact for Daniel C. Adelman
2017-12-29